Quality of life assessment of 80 cases of persistent allergic rhinitis in adults before and after treatment
10.3969/j.issn.1671-8348.2013.31.019
- VernacularTitle:80例成人持续性变应性鼻炎治疗前后生活质量评估
- Author:
Wei ZHANG
;
Yiwen YOU
;
Miao GU
;
Jing CHEN
;
Qiang WANG
- Publication Type:Journal Article
- Keywords:
allergic rhinitis;
persistent;
treatment;
quality of life
- From:
Chongqing Medicine
2013;(31):3776-3778
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the health-relate quality of life(QOL) status of adult persistent allergic rhinitis (PAR);the change of QOL of pro-post specific immunotherapy (SIT) and pharmacotherapy .Methods Skin prick tests(SPT) were performed on PAR patients .According to the results ,80 adult cases that were allergic to dermatophagoides were enrolled in ENT outpatient clinic of affiliated hospital of Nantong University from April to August 2011 .The patients were randomly allocated to receive either specific immunotherapy(n=40) or pharmacotherapy (n=40) ,all of them were given RQLQ before and after half-year treatment ;40 cases without any allergic diseases were chosen from ENT in-patient department ,and were given RQLQ .The scores of previous treatment of the PAR group were compared with health control group ,then compared with the scores of post-treatment ,and also compared the scores of post-treatment between the immunotherapy group and pharmacotherapy group .Results The scores of the PAR patients were higher than that of health control patients in all dimensions of RQLQ (P< 0 .05) ,and the most troublesome problems were nasal symptoms .The scores of the patients who received SIT were evidently lower than that of pro-treatment in all dimensions of RQLQ(P<0 .05) ,the scores of the patients who received medical treatment were also lower than before (P<0 .05) , and the scores of the SIT group were lower than the pharmacotherapy group (P<0 .05) .Conclusion The QOL of adult patients with PAR was improved after SIT or drug treatment ,and QOL improvement is more obvious treat by SIT .
